Risk for specific hematologic cancers down with GLP-1 receptor agonist use in type 2 diabetes
For patients with type 2 diabetes (T2D), glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with a reduced ...
Avocadu on MSN4h
Microdosing GLP-1s: A New Approach to Weight Loss and Metabolic Health
If you’ve been paying attention to the weight loss world, you’ve probably heard about GLP-1 receptor agonists like Ozempic, ...
FDA Inspection Seminar: Preparations for Pharmaceutical and Medical Device Professionals (ON-DEMAND)
The "FDA Inspection" training has been added to ResearchAndMarkets.com's offering. This seminar provides the fundamentals and the ground rules on how to prepare for and survive an FDA inspection no ...
News-Medical.Net20h
GLP-1 drugs may cut risk of leukemia and lymphoma in type 2 diabetes patients
Researchers found that GLP-1 receptor agonists (GLP-1RAs) significantly reduce the risk of several blood cancers in type 2 ...